ONCAlert | 2018 ASCO Annual Meeting
Videos  >  

Stimulating the Immune System With Coxsackievirus in Advanced Cancer Patients

Charles M. Rudin, MD, PhD
Published Online:12:00 PM, Sat May 27, 2017

Charles M. Rudin, MD, PhD, chief, thoracic oncology, Memorial Sloan Kettering Cancer, discusses a study of intravenously delivered coxsackievirus A21 with pembrolizumab to treat patients with advanced cancers.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.